Globus Medical (GMED) Current Deferred Revenue (2017 - 2026)

Globus Medical's Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $34.9 million for Q1 2026.

• Quarterly Current Deferred Revenue rose 103.22% year-over-year to $34.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.9 million (up 103.22% YoY) and the FY2025 annual result came in at $36.9 million, up 66.73% from the prior year.
• Current Deferred Revenue was $34.9 million for Q1 2026 at Globus Medical, down from $36.9 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $36.9 million in Q4 2025 and bottomed at $11.8 million in Q1 2022.
• A 5-year average of $19.3 million and a median of $18.0 million in 2023 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2025 — Current Deferred Revenue dropped 12.19% — and 2026, when it surged 103.22%.
• Globus Medical's Current Deferred Revenue stood at $14.1 million in 2022, then soared by 30.28% to $18.4 million in 2023, then grew by 20.53% to $22.1 million in 2024, then soared by 66.73% to $36.9 million in 2025, then retreated by 5.46% to $34.9 million in 2026.
• Business Quant data shows GMED's Current Deferred Revenue at $34.9 million in Q1 2026, $36.9 million in Q4 2025, and $18.3 million in Q3 2025.